Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Kidney Transplantation from Thin Basement Membrane Nephropathy Donor.
C. Choi,¹ A. Han,¹ S.-Y. Kim,¹ S. Cho,¹ M.-J. Cho,¹ C. Lee,¹ S. Ahn,¹ S.-K. Min,¹ J. Ha,¹ M. Park,² S. Kim,³ I. Jung,¹ S.-I. Min.¹
¹Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; ²Laboratory Medicine, Korea Organ Donation Agency, Seoul, Republic of Korea; ³Surgery, Myongji Hospital, Goyang, Gyeonggi-do, Republic of Korea.
PurposeThin basement membrane nephropathy (TBMN) is the most common cause of persistent glomerular hematuria. Most individuals with TBMN shows benign course, but it is hard…
2016 American Transplant Congress
Kidney Transplant Outcomes in Patients with CPRA Values >98% After Implementation of the New OPTN/UNOS Kidney Allocation System (KAS): A Single Center Study Update.
N. Kaur,¹ S. Goral,¹ J. Kearns,² P. Abt,³ A. Naji,³ P. Porrett,³ M. Levine,³ M. Kamoun.²
¹Renal, Electrolyte and Hypertension Division, University of Pennsylvania Medical Center, Philadelphia; ²Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia; ³Surgery, University of Pennsylvania Medical Center, Philadelphia.
Background: Sensitized patients have had prolonged waiting times and greater incidence of death while on the waiting list. On December 4, 2014, UNOS/OPTN activated a…
2016 American Transplant Congress
Use of Preoperative Embolization Prior to Transplant Nephrectomy.
C. Yeast, J. Riley, J. Holyoak, S. Weinstein, G. Ross, M. Wakefield.
Urology, University of Missouri, Columbia, MO.
Introduction/Objective: After a failed transplant, management of a non-functional graft with pain or recurrent infections can be challenging. Transplant nephrectomy (TN) can be a very…
2016 American Transplant Congress
Kinetics of Cytomegalovirus Load in Kidney Transplant Recipients Receiving Everolimus or Mycophenolate Sodium and No Pharmacological Prophylaxis.
G. Basso, C. Felipe, A. Ferreira, M. Cristelli, N. Oliveira, T. Sandes-Freitas, J. Mansur, L. Viana, W. Aguiar, E. Campos, M. Gerbasi-DeLima, H. Tedesco-Silva, J. Medina-Pestana.
Hospital do Rim, São Paulo, Brazil.
The purpose of this analysis is to investigate the kinetics of cytomegalovirus (CMV) viral load in kidney transplant recipients receiving tacrolimus (TAC) plus everolimus (EVR)…
2016 American Transplant Congress
HCV, Acute Rejection, and the New Direct-Acting Antivirals in Deceased Donor Kidney Transplant Recipients.
C. Liao, A. Massie, S. Bae, D. Segev.
JHU, Baltimore.
The association between hepatitis C virus (HCV) seropositivity and acute rejection (AR) in kidney transplant donors and recipients is unclear, and may have changed with…
2016 American Transplant Congress
Alloimmunity Through Non-HLA Epitopes in Kidney Transplantation.
R. Reindl-Schwaighofer,¹ A. Kainz,¹ B. Cole,² J. van Setten,² K. Jelencsics,¹ B. Keating,² R. Oberbauer.¹
¹Department of Nephrology, Medical University of Vienna, Vienna, Austria; ²Transplant Division, University of Pennsylvania, Philadelphia, PA.
Introduction: An unexpected diversity in the human genome has been identified including more than 2,500 nonsynonymous single nucleotide polymorphisms (nsSNP) and up to 20 homozygous…
2016 American Transplant Congress
Risk Factors for Clinical Urinary Tract Infections in Kidney Transplant Recipients with Asymptomatic Bacteriuria.
S. Medani, M. Dorais, A. Tavares-Brum, H. Mawad, A. Duclos, C. Lemieux, A. Barama, H. Cardinal.
Centre Hospitalier de l'Université de Montréal, Montréal, Canada.
BackgroundThere is no clear consensus on whether asymptomatic bacteriuria (ABU) should be treated in kidney transplant recipients (KTRs). We sought to identify patient or episode…
2016 American Transplant Congress
Preservation of Alloreactive and Antiviral Immunity After Switch to Belatacept-Based Regimen After Kidney Transplantation.
J. Schaenman,¹ Y. Korin,² T. Sidwell,² V. Groysberg,² J. Gadzhyan,¹ E. Lum,¹ U. Reddy,¹ E. Huang,¹ T. Pham,¹ G. Danovitch,¹ E. Reed,² S. Bunnapradist.¹
¹Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA; ²Department of Pathology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Purpose: We set out to investigate the impact of switch from calcineurin inhibitor (CNI) to belatacept on T cell mediated allo- and EBV-specific immunity.Methods: We…
2016 American Transplant Congress
Differences in Reported Barriers to Immunosuppression Adherence Among a Cohort of Pediatric Renal Transplant Recipients from the United States and Canada.
O. Bignall II,^1,2 A. Pai,² S. Amaral,³ S. Furth,³ N. Bergman,² J. Goebel,⁴ The TAKE-IT Study Investigators, B. Foster.⁵
¹Nephrology and Hypertension, Cincinnati Children's Hospital, Cincinnati, OH; ²Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital, Cincinnati, OH; ³Nephrology, The Children's Hospital of Philadelphia, Philadelphia, PA; ⁴Nephrology, Children's Hospital of Colorado, Aurora, CO; ⁵Nephrology, Montreal Children's Hospital, Montreal, QC, Canada.
Aim: The purpose of this study was to examine differences in reported barriers to immunosuppressant adherence (IA) between a cohort of pediatric renal transplant recipients…
2016 American Transplant Congress
Evaluation of Polyomavirus (BK) Treatment and Clinical Outcomes in Pediatric Kidney Transplant Recipients: A >10 Year Single Center Retrospective Experience.
R. Liverman,¹ E. Kraus,¹ R. Garro,² B. Warshaw,² P. Winterberg,² R. George.²
¹Children's Healthcare of Atlanta, Atlanta, GA; ²Division of Pediatric Nephrology, Emory University School of Medicine, Atlanta, GA.
BK viremia (BKV) is a serious infectious complication after kidney transplantation and can lead to BK nephropathy (BKN) and allograft loss. We reviewed our experience…